• 1
    Lin SM, Sheen IS, Chien RN et al. Long-term beneficial effects of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999; 29: 9715.
  • 2
    Shiffman ML, Hofmann CM, Melissa J et al. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology 1999; 117: 116472.
  • 3
    Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 34756.
  • 4
    Poynard T. Safety of standard interferon and ribavirin. In: PoynardT, ed. Hepatitis B and C: management and treatment. London: Martin Dunitz, 2002: 11922.
  • 5
    Vial T, Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 1995; 105: 3157.
  • 6
    Stylianou E, Aukrust P, Muller F, Nordoy I, Froland SS. Complex effects of interferon-alpha on the cytokine network in HIV infection—possible contribution to immunosuppression. Cytokine 2001; 7(14): 5662.
  • 7
    Ferenci P, Vogel W, Pristautz H et al. One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b. J Hepatol 1990; 11(suppl 1): 503.
  • 8
    Irainick U, Kantarjian H, Broussard S, Talpaz M. Local cutaneous necrotizing lesions associated with interferon injections. J Interferon Cytokine Res 1998; 18: 8237.
  • 9
    Philippot V, Yassir F, Balme B, Perrot H. Mycobacterium avium-intracellulare subcutaneous abscess after injections of interferon-alpha in a patient treated for lymphoma. Ann Dermatol Venereol 1996; 123: 1035.
  • 10
    Hofmann V, Fehr J, Sauter C, Ottino J. Hairy cell leukemia: an interferon deficient disease? Cancer Treat Rev 1985; 12(suppl B): 337.
  • 11
    Federico M, Frassoldati A, Lamparelli T et al. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL. Ann Oncol 1994; 5: 72531.
  • 12
    Tummarello D, Graziano F, Isidori P et al. Consolidation biochemotherapy for patients with advanced non-small cell lung carcinoma responding to induction PVM regimen. Cancer 1996; 77: 22517.
  • 13
    Matsuo T, Shinzawa H, Sugahara K, Takahashi T. Case report: a patient who developed an amoebic liver abscess during treatment with interferon. J Gastroenterol Hepatol 1998; 13: 106871.